Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437. Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.” Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609. Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608. Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608. Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy." Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. Art of Medicine May 2023 A Completely Normal Conversation With a Box Beck Regan Health professional students often attend lectures equating resiliency with self-care. AMA J Ethics. 2023;25(5):E378-379. doi: 10.1001/amajethics.2023.378. Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Viewpoint May 2022 Reimagining Roles of Dietary Supplements in Psychiatric Care Katherine Wu, MD and Erik Messamore, MD, PhD Government-supported review and safety monitoring is needed for dietary supplements’ use in the care of patients with mental illness. AMA J Ethics. 2022;24(5):E437-442. doi: 10.1001/amajethics.2022.437.
Podcast May 2022 Author Interview: “Reimagining Roles of Dietary Supplements in Psychiatric Care” Dr Katherine Wu joins Ethics Talk to discuss her article, coauthored with Dr Erik Messamore: “Reimagining Roles of Dietary Supplements in Psychiatric Care.”
Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609.
Case and Commentary Aug 2006 Dermatology Lab Referrals: Cash Cow or Ethical Trap? Jane M. Grant-Kels, MD and Barry D. Kels, MD, JD Virtual Mentor. 2006;8(8):499-502. doi: 10.1001/virtualmentor.2006.8.8.ccas2-0608.
Case and Commentary Aug 2006 Dispensing Cosmeceuticals from the Office Michael H. Gold, MD Virtual Mentor. 2006;8(8):503-508. doi: 10.1001/virtualmentor.2006.8.8.ccas1-0608.
Podcast Jul 2023 Author Interview: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy” Dr Madeline Ward joins Ethics Talk to discuss her article: “Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy."
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
Art of Medicine May 2023 A Completely Normal Conversation With a Box Beck Regan Health professional students often attend lectures equating resiliency with self-care. AMA J Ethics. 2023;25(5):E378-379. doi: 10.1001/amajethics.2023.378.
Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472.